Subcellular elements responsive to the biomechanical activity of triple-negative breast cancer-derived small

Beatrice Senigagliesi1,2, Diana E Bedolla2,3, Giovanni Birarda2

  • 1Scuola Internazionale Superiore di Studi Avanzati, Trieste, Italy.

Biomolecular Concepts
|December 9, 2022
PubMed

Insights

Triple-negative breast cancer (TNBC) spreading involves small extracellular vesicles (sEVs). These TNBC-derived sEVs soften cells by decondensing chromatin, offering new insights for cancer theranostics.

Area of Science:

  • Oncology
  • Cell Biology
  • Biophysics

Background:

  • Triple-negative breast cancer (TNBC) is aggressive, metastatic, and resistant to hormonal therapy, presenting a poor prognosis.
  • Small extracellular vesicles (sEVs) mediate intercellular communication, influencing cancer progression, metastasis, and drug resistance.
  • TNBC-derived sEVs are known to affect target cell proliferation, metastasis, and biomechanical properties.

Purpose of the Study:

  • To investigate the molecular mechanisms by which TNBC-derived sEVs alter the biomechanical properties of recipient cells.
  • To elucidate the role of sEVs in modulating cell membrane, cytoskeleton, and nuclear chromatin organization.

Main Methods:

  • Analysis of TNBC-derived sEVs' effects on recipient cell biomechanics.
  • Investigation of subcellular changes including cell membrane, cytoskeleton, and chromatin organization.

Main Results:

  • TNBC-derived sEVs induce the formation and elongation of cellular protrusions.
  • Recipient cells exhibit a softened cell body after exposure to TNBC-derived sEVs.
  • TNBC-derived sEVs cause decondensation of nuclear chromatin, which appears to be the primary driver of cell softening.

Conclusions:

  • TNBC-derived sEVs actively remodel recipient cell biomechanics through chromatin decondensation.
  • This study reveals a novel mechanism of action for TNBC-derived sEVs.
  • Findings provide crucial information for the development of sEV-based cancer theranostics.

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.8K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K
Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.6K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K